FDA inspection
Fujian South Pharmaceutical Co., Ltd: FDA inspection ending Oct 11, 2024
FDA inspection 1255220 · No Action Indicated (NAI) · Mingxi County
Key facts
| Inspection ID | 1255220 |
|---|---|
| Firm | Fujian South Pharmaceutical Co., Ltd |
| FEI number | 3008467694 |
| Address | Mingxi County, No. 98 Dongxin Road; Xuefengzhen Mingxixian |
| City | Mingxi County |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Oct 11, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data